Prescription dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist used for type 2 diabetes and chronic weight management when prescribed under an FDA-approved label.
Low intrinsic hypoglycemia risk as monotherapy, but risk rises with insulin or sulfonylureas
What to watch for
Nausea
Vomiting
Diarrhea
Personal or family history of medullary thyroid carcinoma (MTC)4
Multiple endocrine neoplasia syndrome type 2 (MEN 2)
The bottom line
Evidence rating strong. Most-documented uses: lowers hba1c in type 2 diabetes, substantial weight loss in chronic weight-management trials, once-weekly subcutaneous administration. 5 sources indexed (2021–2026), with 6 interaction records on file.
The science
How it works, mechanistically.
Core mechanism
Activates GIP and GLP-1 receptors, increasing glucose-dependent insulin secretion, lowering glucagon, slowing gastric emptying, reducing appetite, and improving glycemic control and body weight in indicated populations.3
Class
Dual GIP/GLP-1 Receptor Agonist
Dosing
Dosing & protocol.
Common range
2.5-15 mg subcutaneous injection once weekly, titrated per prescribing information
Recommended form
FDA-approved prefilled pen or vial/syringe product prescribed by a clinician
Subcutaneous prescription medication; food timing is not the primary driver of exposure.
Safety
Full safety detail.
Side effects
Nausea
Vomiting
Diarrhea
Constipation
Abdominal pain or dyspepsia
Injection-site reactions
Hypoglycemia when combined with insulin or sulfonylureas
Pancreatitis and gallbladder disease have been reported
Contraindications
Personal or family history of medullary thyroid carcinoma (MTC)4
Multiple endocrine neoplasia syndrome type 2 (MEN 2)
Known serious hypersensitivity to tirzepatide or product excipients1,2
Pregnancy or planned pregnancy unless directed by the prescribing clinician
Both tirzepatide and berberine can lower blood glucose through complementary mechanisms, creating a clinically important hypoglycemia risk when combined, especially if insulin or sulfonylureas are also used.
Recommendation: Do not add berberine to tirzepatide therapy without prescriber supervision. If both are used, monitor blood glucose closely during initiation and dose changes and carry fast-acting glucose.
Alpha-lipoic acid may improve insulin sensitivity and lower glucose, which can add to tirzepatide's glucose-lowering effects.
Recommendation: Use caution when combining alpha-lipoic acid with tirzepatide. Monitor blood glucose more often when starting or changing alpha-lipoic acid, especially if also taking insulin or sulfonylureas.
Chromium may enhance insulin signaling and glucose metabolism, adding to tirzepatide's glucose-lowering effect.
Recommendation: Low-dose chromium in a multivitamin is usually low risk. Use caution with high-dose chromium supplements and monitor glucose when starting or changing dose.
Fenugreek can lower glucose and slow carbohydrate absorption, while tirzepatide lowers glucose and slows gastric emptying. Combining them can worsen nausea, bloating, constipation, or hypoglycemia risk in susceptible users.
Recommendation: Tell your prescriber before combining fenugreek with tirzepatide. Monitor glucose for 2-4 weeks and stop or reduce fenugreek if GI symptoms worsen.
Ginger may help nausea during tirzepatide titration. It does not address severe or persistent GI symptoms, dehydration, or pancreatitis warning signs.
Recommendation: For mild nausea, ginger tea or modest supplemental ginger with meals may be reasonable. Seek medical guidance for persistent vomiting, severe abdominal pain, dehydration, or inability to keep fluids down.
Psyllium can complement tirzepatide for postprandial glucose and constipation support, but additive GI slowing can worsen bloating or early satiety.
Recommendation: Increase psyllium gradually with plenty of water. Pause or reduce if bloating, constipation, or early satiety worsens during tirzepatide titration.
FDA warns that unapproved GLP-1 versions, including semaglutide and tirzepatide products, do not undergo FDA review for safety, effectiveness, or quality.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Tirzepatide in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.